253 related articles for article (PubMed ID: 25986915)
1. Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis.
Guo R; Cai L; Fan Y; Jin J; Zhou L; Zhang K
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):221-8. PubMed ID: 25986915
[TBL] [Abstract][Full Text] [Related]
2. The role of Prostate Imaging Reporting and Data System score in Gleason 3 + 3 active surveillance candidates enrollment: a diagnostic meta-analysis.
Zhai L; Fan Y; Meng Y; Feng X; Yu W; Jin J
Prostate Cancer Prostatic Dis; 2019 May; 22(2):235-243. PubMed ID: 30429594
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.
Salami SS; Vira MA; Turkbey B; Fakhoury M; Yaskiv O; Villani R; Ben-Levi E; Rastinehad AR
Cancer; 2014 Sep; 120(18):2876-82. PubMed ID: 24917122
[TBL] [Abstract][Full Text] [Related]
4. Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study.
Margel D; Yap SA; Lawrentschuk N; Klotz L; Haider M; Hersey K; Finelli A; Zlotta A; Trachtenberg J; Fleshner N
J Urol; 2012 Apr; 187(4):1247-52. PubMed ID: 22335871
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric magnetic resonance imaging characterization of prostate lesions in the active surveillance population: incremental value of magnetic resonance imaging for prediction of disease reclassification.
Bonekamp D; Bonekamp S; Mullins JK; Epstein JI; Carter HB; Macura KJ
J Comput Assist Tomogr; 2013; 37(6):948-56. PubMed ID: 24270118
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer.
Stamatakis L; Siddiqui MM; Nix JW; Logan J; Rais-Bahrami S; Walton-Diaz A; Hoang AN; Vourganti S; Truong H; Shuch B; Parnes HL; Turkbey B; Choyke PL; Wood BJ; Simon RM; Pinto PA
Cancer; 2013 Sep; 119(18):3359-66. PubMed ID: 23821585
[TBL] [Abstract][Full Text] [Related]
7. Reliability of Serial Prostate Magnetic Resonance Imaging to Detect Prostate Cancer Progression During Active Surveillance: A Systematic Review and Meta-analysis.
Rajwa P; Pradere B; Quhal F; Mori K; Laukhtina E; Huebner NA; D'Andrea D; Krzywon A; Shim SR; Baltzer PA; Renard-Penna R; Leapman MS; Shariat SF; Ploussard G
Eur Urol; 2021 Nov; 80(5):549-563. PubMed ID: 34020828
[TBL] [Abstract][Full Text] [Related]
8. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
Salami SS; Ben-Levi E; Yaskiv O; Ryniker L; Turkbey B; Kavoussi LR; Villani R; Rastinehad AR
BJU Int; 2015 Apr; 115(4):562-70. PubMed ID: 25252133
[TBL] [Abstract][Full Text] [Related]
9. Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.
Hoeks CM; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Roobol MJ; Bul M; Hambrock T; Witjes JA; Fütterer JJ; Hulsbergen-van de Kaa CA; Barentsz JO
Invest Radiol; 2014 Mar; 49(3):165-72. PubMed ID: 24220253
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review.
Schoots IG; Petrides N; Giganti F; Bokhorst LP; Rannikko A; Klotz L; Villers A; Hugosson J; Moore CM
Eur Urol; 2015 Apr; 67(4):627-36. PubMed ID: 25511988
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scoring in a transperineal prostate biopsy setting.
Grey AD; Chana MS; Popert R; Wolfe K; Liyanage SH; Acher PL
BJU Int; 2015 May; 115(5):728-35. PubMed ID: 25041307
[TBL] [Abstract][Full Text] [Related]
12. Magnetic Resonance Imaging Targeted Biopsy Improves Selection of Patients Considered for Active Surveillance for Clinically Low Risk Prostate Cancer Based on Systematic Biopsies.
Ouzzane A; Renard-Penna R; Marliere F; Mozer P; Olivier J; Barkatz J; Puech P; Villers A
J Urol; 2015 Aug; 194(2):350-6. PubMed ID: 25747105
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-analysis.
Woo S; Suh CH; Kim SY; Cho JY; Kim SH
Eur Urol; 2017 Aug; 72(2):177-188. PubMed ID: 28196723
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of diffusion-weighted MRI in the differential diagnosis of lung lesions.
Chen L; Zhang J; Bao J; Zhang L; Hu X; Xia Y; Wang J
J Magn Reson Imaging; 2013 Jun; 37(6):1351-8. PubMed ID: 23239425
[TBL] [Abstract][Full Text] [Related]
15. [Active surveillance in prostate cancer: Assessment of MRI in the selection and follow-up of patients].
Raichi A; Marcq G; Fantoni JC; Puech P; Villers A; Ouzzane A
Prog Urol; 2018 Jun; 28(8-9):416-424. PubMed ID: 29861328
[TBL] [Abstract][Full Text] [Related]
16. Can the Use of Serial Multiparametric Magnetic Resonance Imaging During Active Surveillance of Prostate Cancer Avoid the Need for Prostate Biopsies?-A Systematic Diagnostic Test Accuracy Review.
Hettiarachchi D; Geraghty R; Rice P; Sachdeva A; Nambiar A; Johnson M; Gujadhur R; Mcneill M; Haslam P; Soomro N; Zeeshan Hameed BM; Somani B; Veeratterapillay R; Rai BP
Eur Urol Oncol; 2021 Jun; 4(3):426-436. PubMed ID: 32972894
[TBL] [Abstract][Full Text] [Related]
17. Imaging Characteristics of Prostate Cancer Patients Who Discontinued Active Surveillance on 3-T Multiparametric Prostate MRI.
Habibian DJ; Liu CC; Dao A; Kosinski KE; Katz AE
AJR Am J Roentgenol; 2017 Mar; 208(3):564-569. PubMed ID: 28075651
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis.
Woo S; Suh CH; Kim SY; Cho JY; Kim SH
Eur Urol; 2018 Jan; 73(1):81-91. PubMed ID: 28412063
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer.
Numao N; Yoshida S; Komai Y; Ishii C; Kagawa M; Kijima T; Yokoyama M; Ishioka J; Matsuoka Y; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
J Urol; 2013 Aug; 190(2):502-8. PubMed ID: 23473904
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
